Search alternatives:
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
g decrease » a decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
50 mg » 10 mg (Expand Search)
5 g » 5 mg (Expand Search)
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
we decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
g decrease » a decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
50 mg » 10 mg (Expand Search)
5 g » 5 mg (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
7
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…(A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
8
-
9
-
10
-
11
-
12
-
13
-
14
Metformin lotion decreases TGF-β1 levels in the wounded skin of rats after 10 days of wound healing.
Published 2024Subjects: -
15
-
16
Nasal mucociliary clearance was decreased in <i>Ttll1</i><sup>−/−</sup> mice.
Published 2015“…<p>(A) Tosufloxacin (50 mg/kg) was administered to <i>Ttll1</i><sup>−/−</sup> mice with rhinosinusitis to inhibit cough for 7 days. …”
-
17
Proportion of participants with sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment value and to < 8100 mf/ml.
Published 2016“…<p>Proportion of participants with sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment value and to < 8100 mf/ml.…”
-
18
-
19
-
20